Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Can

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Journal of Cancer Research and Clinical Oncology|August 12, 2022
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort studyDeniz Can Guven, Emre Yekeduz, Enes Erul, et al.
Cancer Medicine|December 18, 2024
Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers-Based ModelMaria Colomba Comes, Annarita Fanizzi, Samantha Bove, et al.
Expert Review of Anticancer Therapy|July 4, 2025
Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income countryOnur Baş, Leyla Sert, Onur Yazdan Balçık, et al.
Future Oncology (London, England)|November 11, 2021
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experienceOmer Diker, Burak Yasin Aktas, Recep Ak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2023
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancerGörkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, et al.
Turkish Journal of Urology|April 5, 2021
Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinomaOktay Halit Aktepe, Gürkan Güner, Deniz Can Güven, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysisElsa Vitale, Andrey Soares, Alessandro Rizzo, et al.
Journal of Clinical Medicine|August 12, 2022
The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with ImmunotherapyDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 28, 2020
Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Taha Koray Sahin, Melek Seren Aksun, et al.
Turkish Journal of Medical Sciences|June 15, 2019
Evaluation of cancer risk in patients with periodontal diseasesDeniz Can Güven, Ömer Dizdar, Abdullah Cevdet Akman, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Journal of Cancer Research and Clinical Oncology|August 12, 2022
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort studyDeniz Can Guven, Emre Yekeduz, Enes Erul, et al.
Cancer Medicine|December 18, 2024
Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers-Based ModelMaria Colomba Comes, Annarita Fanizzi, Samantha Bove, et al.
Expert Review of Anticancer Therapy|July 4, 2025
Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income countryOnur Baş, Leyla Sert, Onur Yazdan Balçık, et al.
Future Oncology (London, England)|November 11, 2021
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experienceOmer Diker, Burak Yasin Aktas, Recep Ak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2023
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancerGörkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, et al.
Turkish Journal of Urology|April 5, 2021
Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinomaOktay Halit Aktepe, Gürkan Güner, Deniz Can Güven, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysisElsa Vitale, Andrey Soares, Alessandro Rizzo, et al.
Journal of Clinical Medicine|August 12, 2022
The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with ImmunotherapyDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 28, 2020
Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Taha Koray Sahin, Melek Seren Aksun, et al.
Turkish Journal of Medical Sciences|June 15, 2019
Evaluation of cancer risk in patients with periodontal diseasesDeniz Can Güven, Ömer Dizdar, Abdullah Cevdet Akman, et al.
Pageof 20